These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28956865)

  • 1. Effects of Amprenavir on HIV-1 Maturation, Production and Infectivity Following Drug Withdrawal in Chronically-Infected Monocytes/Macrophages.
    Borrajo A; Ranazzi A; Pollicita M; Bruno R; Modesti A; Alteri C; Perno CF; Svicher V; Aquaro S
    Viruses; 2017 Sep; 9(10):. PubMed ID: 28956865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent antiviral activity of amprenavir in primary macrophages infected by human immunodeficiency virus.
    Aquaro S; Guenci T; Di Santo F; Francesconi M; Caliò R; Perno CF
    Antiviral Res; 2004 Feb; 61(2):133-7. PubMed ID: 14670588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus.
    Perno CF; Newcomb FM; Davis DA; Aquaro S; Humphrey RW; Caliò R; Yarchoan R
    J Infect Dis; 1998 Aug; 178(2):413-22. PubMed ID: 9697721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-macrophage colony-stimulating factor inhibits HIV-1 replication in monocyte-derived macrophages.
    Kedzierska K; Maerz A; Warby T; Jaworowski A; Chan H; Mak J; Sonza S; Lopez A; Crowe S
    AIDS; 2000 Aug; 14(12):1739-48. PubMed ID: 10985310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference of interleukin-10 with human immunodeficiency virus type 1 replication in primary monocyte-derived macrophages.
    Kootstra NA; van 't Wout A; Huisman HG; Miedema F; Schuitemaker H
    J Virol; 1994 Nov; 68(11):6967-75. PubMed ID: 7933078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic hypersusceptibility to multiple protease inhibitors and low replicative capacity in patients who are chronically infected with human immunodeficiency virus type 1.
    Martinez-Picado J; Wrin T; Frost SD; Clotet B; Ruiz L; Brown AJ; Petropoulos CJ; Parkin NT
    J Virol; 2005 May; 79(10):5907-13. PubMed ID: 15857976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection of human monocytes with Mycobacterium tuberculosis enhances human immunodeficiency virus type 1 replication and transmission to T cells.
    Mancino G; Placido R; Bach S; Mariani F; Montesano C; Ercoli L; Zembala M; Colizzi V
    J Infect Dis; 1997 Jun; 175(6):1531-5. PubMed ID: 9180201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystamine inhibits HIV type 1 replication in cells of monocyte/macrophage and T cell lineages.
    Ho WZ; Zhu XH; Song L; Lee HR; Cutilli JR; Douglas SD
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):451-9. PubMed ID: 7632461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human immunodeficiency virus type-1 replication in macrophages and H9 cells by free or liposome-encapsulated L-689,502, an inhibitor of the viral protease.
    Pretzer E; Flasher D; Düzgüneş N
    Antiviral Res; 1997 Mar; 34(1):1-15. PubMed ID: 9107381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-13 acts on macrophages to block the completion of reverse transcription, inhibit virus production, and reduce virus infectivity.
    Montaner LJ; Bailer RT; Gordon S
    J Leukoc Biol; 1997 Jul; 62(1):126-32. PubMed ID: 9226003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral efficacy of the novel compound BIT225 against HIV-1 release from human macrophages.
    Khoury G; Ewart G; Luscombe C; Miller M; Wilkinson J
    Antimicrob Agents Chemother; 2010 Feb; 54(2):835-45. PubMed ID: 19995924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Tat-conjugated ritonavir-loaded nanoparticles in reducing HIV-1 replication in monocyte-derived macrophages and cytocompatibility with macrophages and human neurons.
    Borgmann K; Rao KS; Labhasetwar V; Ghorpade A
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):853-62. PubMed ID: 21175357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus type-1 (HIV-1) infection increases the sensitivity of macrophages and THP-1 cells to cytotoxicity by cationic liposomes.
    Konopka K; Pretzer E; Felgner PL; Düzgüneş N
    Biochim Biophys Acta; 1996 Jul; 1312(3):186-96. PubMed ID: 8703987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically infected macrophages.
    Perno CF; Bergamini A; Pesce CD; Milanese G; Capozzi M; Aquaro S; Thaisrivongs S; Tarpley WG; Zon G; D'Agostini C
    J Infect Dis; 1993 Nov; 168(5):1148-56. PubMed ID: 8228348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1-based defective lentiviral vectors efficiently transduce human monocytes-derived macrophages and suppress replication of wild-type HIV-1.
    Zeng L; Planelles V; Sui Z; Gartner S; Maggirwar SB; Dewhurst S; Ye L; Nerurkar VR; Yanagihara R; Lu Y
    J Gene Med; 2006 Jan; 8(1):18-28. PubMed ID: 16142830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of replication-competent HIV type 1-infected circulating monocytes from individuals receiving antiretroviral therapy.
    Harrold SM; Wang G; McMahon DK; Riddler SA; Mellors JW; Becker JT; Caldararo R; Reinhart TA; Achim CL; Wiley CA
    AIDS Res Hum Retroviruses; 2002 Apr; 18(6):427-34. PubMed ID: 11958686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibition of HIV replication in monocytes by interleukin 10 is linked to inhibition of cell differentiation.
    Chang J; Naif HM; Li S; Jozwiak R; Ho-Shon M; Cunningham AL
    AIDS Res Hum Retroviruses; 1996 Sep; 12(13):1227-35. PubMed ID: 8870844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Modified P1 Moiety Enhances In Vitro Antiviral Activity against Various Multidrug-Resistant HIV-1 Variants and In Vitro Central Nervous System Penetration Properties of a Novel Nonpeptidic Protease Inhibitor, GRL-10413.
    Amano M; Salcedo-Gómez PM; Zhao R; Yedidi RS; Das D; Bulut H; Delino NS; Sheri VR; Ghosh AK; Mitsuya H
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7046-7059. PubMed ID: 27620483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cells.
    Tsai WP; Conley SR; Kung HF; Garrity RR; Nara PL
    Virology; 1996 Dec; 226(2):205-16. PubMed ID: 8955040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel delivery system enhances efficacy of antiretroviral therapy in animal model for HIV-1 encephalitis.
    Spitzenberger TJ; Heilman D; Diekmann C; Batrakova EV; Kabanov AV; Gendelman HE; Elmquist WF; Persidsky Y
    J Cereb Blood Flow Metab; 2007 May; 27(5):1033-42. PubMed ID: 17063148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.